尿激酶治疗急性脑梗死临床观察

Clinical observation of urokinase in the treatment of acute cerebral infarction

目的:观察尿激酶治疗急性脑梗死的疗效。方法:治疗组急性脑梗死32例,在基础治疗的基础上用尿激酶150万U加入生理盐水中静脉滴注。对照组34例,仅用基础治疗,包括改善微循环、钙离子拮抗剂等治疗,比较两组疗效。结果:治疗组有效率83.78%,明显优于对照组(50%),两组副作用无显著差别。结论:尿激酶静脉溶栓治疗急性脑梗死疗效显著,值得临床推广。

Objective： To observe the urokinase treatment of acute cerebral infarction. Methods： Treatment group 32 cases of acute cerebral infarction and treatment on the basis of urokinase with 150 million U join saline of intravenous drip. The control group 34 cases only use the foundation treatment, including the improvement of microcirculation, calcium antagonists, compared with two groups of curative effects. Results： Treatment group effectiveness 83.78%, was better than control group （50%）, there was no significant difference of side effects. Conclusion： Urokinase intravenous thrombolytic therapy in patients with acute cerebral infarction remarkable curative effect, it is worth popularizing.